07:00 , Aug 15, 2013 |  BC Innovations  |  Distillery Therapeutics

Indication: Cancer

Indication Target/marker/pathway Summary Licensing status Publication and contact information Cancer Liver cancer Core 1 synthase glycoprotein-N-acetylgalactosamine 3-b-galactosyltransferase 1 (C1GALT1) Human tissue and mouse studies suggest inhibiting C1GALT1 could help treat hepatocellular carcinoma (HCC). In patient...